Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC, Canada.
Blood. 2011 Aug 18;118(7):1766-73. doi: 10.1182/blood-2010-11-319632. Epub 2011 Jul 5.
Strategies for expanding hematopoietic stem cells (HSCs) could have significant utility for transplantation-based therapies. However, deleterious consequences of such manipulations remain unknown. Here we examined the impact of HSC self-renewal divisions in vitro and in vivo on their subsequent regenerative and continuing ability to sustain blood cell production in the absence of telomerase. HSC expansion in vitro was obtained using a NUP98-HOXA10hd transduction strategy and, in vivo, using a serial transplant protocol. We observed ~ 10kb telomere loss in leukocytes produced in secondary mice transplanted with HSCs regenerated in primary recipients of NUP98-HOXA10hd-transduced and in vitro-expanded Tert(-/-) HSCs 6 months before. The second generation leukocytes also showed elevated expression of γH2AX (relative to control) indicative of greater accumulating DNA damage. In contrast, significant telomere shortening was not detected in leukocytes produced from freshly isolated, serially transplanted wild-type (WT) or Tert(-/-) HSCs, suggesting that HSC replication posttransplant is not limited by telomere shortening in the mouse. These findings document a role of telomerase in telomere homeostasis, and in preserving HSC functional integrity on prolonged self-renewal stimulation.
扩增造血干细胞(HSCs)的策略可能对基于移植的治疗具有重要意义。然而,这种操作的有害后果尚不清楚。在这里,我们研究了体外和体内 HSC 自我更新分裂对其随后在没有端粒酶的情况下再生和继续维持血细胞生成的能力的影响。体外 HSC 扩增是通过 NUP98-HOXA10hd 转导策略获得的,体内扩增是通过连续移植方案获得的。我们观察到,在 NUP98-HOXA10hd 转导和体外扩增的 Tert(-/-)HSCs 再生的原发性受者的次级小鼠中移植的白细胞中,约有 10kb 的端粒丢失,而这些细胞是在 6 个月前接受 HSCs 再生的。第二代白细胞也表现出γH2AX 的表达升高(相对于对照),表明积累的 DNA 损伤更大。相比之下,在新鲜分离的、连续移植的野生型(WT)或 Tert(-/-)HSCs 产生的白细胞中没有检测到明显的端粒缩短,这表明移植后 HSC 的复制不受小鼠中端粒缩短的限制。这些发现证明了端粒酶在端粒稳态和延长自我更新刺激下维持 HSC 功能完整性中的作用。